As shown in Figure 5B, the LMP1-positive NPC (LMP1 expressed in ≧ 10% of tumor cells) patient group had a shorter survival than the LMP1-negative NPC (LMP1 expressed in < 10% of tumor cells) patient group (p = 0.0166, log-rank test). This evidence concerns the gene PDLIM7 and nasopharyngeal carcinoma.